A Retrospective Analysis of Mature T- and NK-cell Lymphomas

Overview

Journal Cancer Biol Med

Specialty Oncology

Date 2024 Mar 28

PMID 38544483

Authors

Junlei Jia

Xiaohui Wang

Zheng Song

Shen Meng

Yue Fei

Jingwei Yu

Xia Liu

Xue Han

Lanfang Li

Lihua Qiu

Zhengzi Qian

Shiyong Zhou

Wenchen Gong

Bin Meng

Xiubao Ren

Xianhuo Wang

Huilai Zhang

Affiliations

Soon will be listed here.

Citing Articles

Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine.

Hu L, Zhang X, Zang S Cancer Biol Med. 2024; 21(9).

PMID: 39119774 PMC: 11414223. DOI: 10.20892/j.issn.2095-3941.2024.0132.

References

Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T . Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer. 1995; 76(11):2351-6. DOI: 10.1002/1097-0142(19951201)76:11<2351::aid-cncr2820761125>3.0.co;2-1. View

Zhang W, Su L, Liu L, Gao Y, Wang Q, Su H . The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study. Cancer Biol Med. 2021; . PMC: 8330529. DOI: 10.20892/j.issn.2095-3941.2020.0413. View

Cheson B, Fisher R, Barrington S, Cavalli F, Schwartz L, Zucca E . Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014; 32(27):3059-68. PMC: 4979083. DOI: 10.1200/JCO.2013.54.8800. View

Li Y, Feng L, Niu S, Wang H, Zhang L, Wang L . Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy. Oncotarget. 2016; 8(7):11480-11488. PMC: 5355279. DOI: 10.18632/oncotarget.14006. View

Maomao C, He L, Dianqin S, Siyi H, Xinxin Y, Fan Y . Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med. 2022; 19(8). PMC: 9425189. DOI: 10.20892/j.issn.2095-3941.2022.0231. View

Gutierrez-Garcia G, Garcia-Herrera A, Cardesa T, Martinez A, Villamor N, Ghita G . Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol. 2010; 22(2):397-404. DOI: 10.1093/annonc/mdq359. View

Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U . Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2003; 103(7):2474-9. DOI: 10.1182/blood-2003-09-3080. View

Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M . Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol. 2012; 138(3):429-34. DOI: 10.1309/AJCP7YLTQPUSDQ5C. View

Chen S, Yang Y, Qi S, Wang Y, Hu C, He X . Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. Leukemia. 2020; 35(1):130-142. PMC: 7787971. DOI: 10.1038/s41375-020-0791-3. View

10.

Sandell R, Boddicker R, Feldman A . Genetic Landscape and Classification of Peripheral T Cell Lymphomas. Curr Oncol Rep. 2017; 19(4):28. PMC: 5517131. DOI: 10.1007/s11912-017-0582-9. View

11.

Swerdlow S, Campo E, Pileri S, Lee Harris N, Stein H, Siebert R . The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20):2375-90. PMC: 4874220. DOI: 10.1182/blood-2016-01-643569. View

12.

Yoon S, Song Y, Kim S, Yoon D, Chen T, Koh Y . Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia. Lancet Reg Health West Pac. 2021; 10:100126. PMC: 8315366. DOI: 10.1016/j.lanwpc.2021.100126. View

13.

Kim S, Yoon D, Jaccard A, Chng W, Lim S, Hong H . A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016; 17(3):389-400. DOI: 10.1016/S1470-2045(15)00533-1. View

14.

Went P, Agostinelli C, Gallamini A, Piccaluga P, Ascani S, Sabattini E . Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006; 24(16):2472-9. DOI: 10.1200/JCO.2005.03.6327. View

15.

Shi Y, Dong M, Hong X, Zhang W, Feng J, Zhu J . Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann Oncol. 2015; 26(8):1766-71. DOI: 10.1093/annonc/mdv237. View

16.

Ansell S, Habermann T, Kurtin P, Witzig T, Chen M, Li C . Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol. 1997; 15(6):2296-301. DOI: 10.1200/JCO.1997.15.6.2296. View